Correlation Between Mastercard Incorporated and FibroGen

Can any of the company-specific risk be diversified away by investing in both Mastercard Incorporated and FibroGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mastercard Incorporated and FibroGen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mastercard Incorporated and FibroGen, you can compare the effects of market volatilities on Mastercard Incorporated and FibroGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mastercard Incorporated with a short position of FibroGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mastercard Incorporated and FibroGen.

Diversification Opportunities for Mastercard Incorporated and FibroGen

-0.08

Correlation Coefficient

Mastercard Incorporated  FibroGen

Good diversification

The 3 months correlation between Mastercard and FibroGen is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Mastercard Incorporated and FibroGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FibroGen and Mastercard Incorporated is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mastercard Incorporated are associated (or correlated) with FibroGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FibroGen has no effect on the direction of Mastercard Incorporated i.e., Mastercard Incorporated and FibroGen go up and down completely randomly.

Pair Corralation between Mastercard Incorporated and FibroGen

Assuming the 90 days horizon Mastercard Incorporated is expected to generate 0.14 times more return on investment than FibroGen. However, Mastercard Incorporated is 6.92 times less risky than FibroGen. It trades about 0.08 of its potential returns per unit of risk. FibroGen is currently generating about -0.02 per unit of risk. If you would invest  662,093  in Mastercard Incorporated on September 23, 2024 and sell it today you would earn a total of  396,033  from holding Mastercard Incorporated or generate 59.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mastercard Incorporated  vs.  FibroGen

Mastercard Incorporated

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mastercard Incorporated are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Mastercard Incorporated may actually be approaching a critical reversion point that can send shares even higher in January 2025.

FibroGen

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days FibroGen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, FibroGen is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Mastercard Incorporated and FibroGen

The main advantage of trading using opposite Mastercard Incorporated and FibroGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mastercard Incorporated position performs unexpectedly, FibroGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroGen will offset losses from the drop in FibroGen's long position.

The idea behind Mastercard Incorporated and FibroGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.